Adjuvant endocrine therapy for post-menopausal women with ductal carcinoma in situ-is the pain worth the gain? A commentary on the NSABP-B35 trial

Kirsty E. Stuart*, John Boyages

*Corresponding author for this work

Research output: Contribution to journalComment/opinionpeer-review

Original languageEnglish
Pages (from-to)S113-S116
Number of pages4
JournalTranslational Cancer Research
Publication statusPublished - Jun 2016

Cite this